Medical Device Tariff Uncertainty: OTC Hearing Aids Offer An Affordable Solution

Nano Hearing Aids, a leader in FDA-registered over-the-counter (OTC) hearing technology, is reinforcing the importance of accessible hearing support amid ongoing US government policy changes that may impact the affordability of medical devices in 2025. While the full scope of recently announced tariffs remains unclear, OTC hearing aids continue to offer a practical and cost-effective solution for individuals with perceived mild to moderate hearing loss.

OTC HEARING AIDS: AFFORDABILITY & PERFORMANCE

Recent tariff policy updates announced by President Trump include a 10 percent baseline tax on foreign goods, raising concerns about potential cost increases in the medical device sector. Though some products may qualify for exemptions under Chapter 98 of the Harmonized Tariff Schedule, the verdict among industry players about which way the tide will turn is still out.

While prescription hearing aids can cost anywhere from $1,000 to over $6,000 a pair, many OTC models—like those offered by Nano Hearing Aids starting at just $297—present a far more affordable option for adults with perceived mild to moderate hearing loss. Regulated by the FDA since 2022, OTC hearing aids do not require a prescription or fitting. Meanwhile, they offer many of the same benefits as prescription models and, as noted by Consumer Reports, are suitable for nearly 90 percent of people with hearing loss.

NANO HEARING AIDS OFFERS OPTIONS AMID MARKET INSTABILITY

“At Nano Hearing Aids, we understand that every individual’s hearing needs are unique,” says Dan Thomas, Vice-President of Operations. “As the market shifts, we remain committed to providing solutions that are both effective and economically accessible.”

These commitments are important as several widely documented studies concerning individuals whose hearing is changing show that hearing aids can improve their quality of life and potentially stave off depression and dementia.

Nano’s OTC lineup includes a range of affordable and user-friendly options, including their discreet Completely-in-Canal (CIC) models and the earbud-style First Ear Plus In-the-Ear (ITE) model.

All Nano OTC hearing devices feature noise reduction, feedback management, and rechargeable batteries. Buttons and controls were engineered to help those with dexterity issues like arthritis make necessary adjustments with ease. And for the tech-savvy segment, Nano offers the Audacity RIC hearing aids - they are Bluetooth-enabled and app-controlled, allowing the user to stream music, take calls through their devices, and make adjustments using the app.

DEMAND FOR OTC HEARING AIDS IN 2025

A 2025 report from Research and Markets reveals the US hearing aid market has witnessed a significant surge in demand, with more adults now turning to OTC hearing aids as a fast and easy solution to mild or moderate hearing loss.

As the dust has yet to settle on the tariff front and with President Trump continuing to vacillate on policy intentions and exemptions, individuals considering OTC hearing aids may want to act now. With a variety of style options and design features suitable for a range of budgets and technical preferences, consumers managing mild to moderate hearing loss should have no trouble finding the right devices for their needs.

About Nano Hearing Aids®

Known for its innovative solutions and customer-centric approach, Nano Hearing Aids® has been a leader in hearing aid technology for nearly a decade. All Nano products are Class 1, OTC compliant, and FDA registered.

Learn more by visiting https://nanohearingaids.com/collections/hearing-aids